<?xml version="1.0" encoding="UTF-8"?>
<p>Eligible participants are all adults aged 18 to 75â€Šyears, diagnosed with magnificent tumor confirmed by clinicopathology or cytology undergoing the cisplatin-based chemotherapy regimens and an expected survival time of &gt;3 months. They are still in relatively good physical condition, with a Kamofsky score &gt;60.</p>
